详情页 - 首都医科大学附属北京同仁医院知识库

资源类型：

文章类型：

作者：

Xu Naiqing[1,2,3] * ; Fang Wenfeng[4] ; Mu Libing[5] ; Tang Yanna[4] ; Gao Lei[2] ; Ren Shengxiang[6] ; Cao Dengfeng[7] ; Zhou Lixin[8] ; Zhang Aiqun[9] ; Liu Deruo[10] ; Zhou Caicun[6] ; Wong Kwok-Kin[11] ; Yu Lei[12]

; Zhang Li[4] ; Chen Liang[1,2,3,13] ;

机构： [1]Graduate School of Peking Union Medical College, Beijing, China. [2]National Institute of Biological Sciences, Beijing, China. [3]Chinese Academy of Medical Sciences, Beijing, China. [4]Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, P. R. China. [5]Tsinghua University School of Medicine, Beijing, China. [6]Shanghai Pulmonary Hospital, Shanghai, China. [7]Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, China. [8]Peking University Cancer Hospital, Beijing, China. [9]General Hospital of People's Liberation Army, Beijing, China. [10]Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China. [11]Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [12]Beijing Tongren Hospital, Capital Medical University, Beijing, China. [13]National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, China.

出处：

DOI：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 3 区细胞生物学

最新[2023]版：

无

第一作者：

第一作者机构： [1]Graduate School of Peking Union Medical College, Beijing, China. [2]National Institute of Biological Sciences, Beijing, China. [3]Chinese Academy of Medical Sciences, Beijing, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.

文献详情